Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes



Rating:

Share or cite this content

Citations should be made in the following way:
M. Shteinberg (Haifa, Israel), E. Polverino (Barcelona, Spain), P. Burgel (Paris, France), C. Haworth (Cambridge, United Kingdom), K. Dimakou (Athens, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menendez (Valenica, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. De-Soyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), A. Shoemark (Dundee, United Kingdom), W. Boersma (Alkmaar, Netherlands), R. Wilson (London, United Kingdom), J. Chalmers (Dundee, United Kingdom), S. Elborn (Belfast, United Kingdom), S. Aliberti (Milan, Italy), P. Goeminne (Sint-Niklaas, Belgium), J. Altenburg (Amsterdam, Netherlands). The microbiology of stable bronchiectasis: data from the EMBARC bronchiectasis registry. 1308

Member's Comments

No comment yet.

Related content which might interest you: Clinical cases: COPD and bronchiectasis Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Allergic bronchopulmonary aspergillosis as aetiology of bronchiectasis: data from the German bronchiectasis registry PROGNOSIS Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections Year: 2020 The management of non-CF bronchiectasis in Europe: data from the European Bronchiectasis Network Source: International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC) Year: 2015 Validity of COPD diagnosis in Bronchiectasis patients: data from the EMBARC registry Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) Year: 2018 Clinical relevance of bronchiectasis in COPD Source: Annual Congress 2010 - COPD: diagnosis Year: 2010 Exacerbations in non cystic fibrosis bronchiectasis: clinical features and investigations Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood Year: 2009 Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC) Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Chest physiotherapy in European patients with bronchiectasis: Data from the EMBARC registry Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Radiological features of NTM pulmonary disease in patients with bronchiectasis Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research Source: Eur Respir J, 49 (6) 1700051; 10.1183/13993003.00051-2017 Year: 2017 The bronchiectasis ‘bacteriophagome’ Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes Year: 2021 Immunodeficits in bronchiectasis Source: International Congress 2017 – PG3 Bronchiectasis Year: 2017 The evaluation of epidemiological data and etiological reasons of bronchiectasis patients Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Characteristics of patients with pulmonary non-tuberculous Mycobacterial infection in bronchiectasis: Data from the EMBARC registry Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) Year: 2018 Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017 Leicester cough questionnaire and sputum colour chart assessment in non-cystic fibrosis bronchiectasis: A cohort analysis Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011